Search Results
1 - PPD Announces Third Quarter 2009 Earnings Release, Webcast and Conference Call
WILMINGTON, N.C.-(Business Wire)-September 29, 2009 - PPD, Inc. (Nasdaq: PPDI) will release its third quarter 2009 financial results on Tuesday, October 27, 2009, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business...
2 - PPD Opens Global Central Lab in Singapore
WILMINGTON, N.C.-(Business Wire)-September 15, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customized laboratory services in Southeast Asia, a...
3 - PPD Names Deborah Covington as Global Head of Observational Studies and Pregnancy Registries
WILMINGTON, N.C.-(Business Wire)-September 9, 2009 - PPD, Inc. (NASDAQ: PPDI) today announced the appointment of Deborah Covington, Dr.PH., as global head of observational studies and pregnancy registries. In this role, she will provide leadership and direction to the company’s late stage group...
4 - PPD to Receive Milestone Payments for First Regulatory Approvals of Priligy™ (Dapoxetine) in Finland and Sweden for Treatment of Premature Ejaculation
WILMINGTON, N.C.-(Business Wire)-February 10, 2009 - PPD, Inc. (NASDAQ:PPDI) today announced it will receive milestone payments from Janssen-Cilag in connection with the recently announced regulatory approvals in Finland and Sweden of Priligy™ (dapoxetine) for the “on-demand” treatment of...
5 - PPD Reports Fourth Quarter and Full Year 2008 Financial Results
WILMINGTON, N.C.-(Business Wire)-February 9, 2009 - PPD, Inc. (NASDAQ:PPDI): Highlights: Q4 2008 new authorizations of $789 million Backlog at December 31, 2008 of $3.2 billion Full year 2008 cash flow from operations of $380 million PPD, Inc. (Nasdaq: PPDI) today reported its financial and...
6 - PPD to Acquire AbCRO
WILMINGTON, N.C.-(Business Wire)-February 9, 2009 - PPD, Inc. (NASDAQ:PPDI) today announced it has entered into an agreement to acquire AbC.R.O., Inc. (AbCRO), a contract research organization operating in Central and Eastern Europe, which will further strengthen PPD’s presence in a high-growth...
7 - PPD Announces Fourth Quarter and Full-Year 2008 Earnings Release, Webcast and Conference Call
WILMINGTON, N.C.-(Business Wire)-January 15, 2009 - PPD, Inc. (Nasdaq: PPDI) will release its fourth quarter and full-year 2008 financial results on Monday, February 9, 2009, after the market closes. The release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business...
8 - PPD Issues 2009 Financial Guidance
WILMINGTON, N.C.-(Business Wire)-January 14, 2009 - PPD, Inc. (Nasdaq: PPDI) today reported its projected 2009 financial guidance. PPD anticipates that net revenue for the full year 2009 will be in the range of $1.595 to $1.670 billion, a projected increase of approximately 12 percent over the...
9 - PPD Expands Post-Approval Drug Safety Capabilities through Strategic Alliance with WHISCON
WILMINGTON, N.C.-(Business Wire)-January 13, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has expanded its post-approval drug safety expertise in epidemiology and risk management through a strategic alliance with World Health Information Science Consultants, LLC (WHISCON), an internationally...
10 - PPD to Present at 27th Annual J.P. Morgan Healthcare Conference
WILMINGTON, N.C.-(Business Wire)-January 6, 2009 - PPD, Inc. (NASDAQ:PPDI) today announced that Fred Eshelman, chief executive officer of PPD, will present an update on PPD’s business at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif., on Monday, January 12, 2009, at...
11 - PPD Enters Into Strategic Collaboration with Merck
WILMINGTON, N.C.-(Business Wire)-January 5, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has entered into a strategic collaboration with Merck & Co., Inc., involving vaccine testing and assay development. Under the agreements, PPD purchased Merck’s 130,000 square-foot vaccine testing...
12 - PPD to Expand Contract Research Operations into Ireland
WILMINGTON, N.C.-(Business Wire)-December 18, 2008 - PPD, Inc. (Nasdaq: PPDI) and IDA Ireland (Investment and Development Agency) today announced that PPD plans to expand its contract research operations into Athlone, Ireland, by initially establishing a cGMP analytical testing laboratory to meet...
